Stay updated on COR388 for AD: Phase 2/3 Clinical Trial

Sign up to get notified when there's something new on the COR388 for AD: Phase 2/3 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the COR388 for AD: Phase 2/3 Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays the GAIN Alzheimer’s disease trial record, including its study design, eligibility criteria, locations, outcomes, and posted documents.
    Difference
    89%
    Check dated 2026-11-10T21:28:22.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T21:31:44.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    A site-wide notice about NIH’s terminology transition appears, and the site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T21:36:10.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1, while the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T20:54:29.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Key study documents such as the Statistical Analysis Plan and Study Protocol were removed from the Study Documents section along with related metadata. This change reduces public access to the trial's methodological details and documentation.
    Difference
    17%
    Check dated 2026-09-22T22:23:15.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0, indicating a new release of the page's software or documentation. This is a maintenance update and does not modify the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-09-15T21:40:32.000Z thumbnail image

Stay in the know with updates to COR388 for AD: Phase 2/3 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the COR388 for AD: Phase 2/3 Clinical Trial page.